This year’s Ergomed AGM was held at the offices of Covington & Burling LLP, 265 Strand, London WC2R 1BH starting at 9.30am on Friday 16 June 2017.
For Investors who are unfamiliar with the company, Ergomed is a hybrid Pharmaceutical Services company offering a complete Clinical Development service for investigational drugs and a Pharmacovigilance monitoring service for marketed products. What makes Ergomed fairly unique amongst its peers is its co-development model, whereby it shares the cost of clinicals trials on new medicines that it runs on behalf of clients in exchange for a royalty (typically 10 – 15%) on sales.
Click here for more details if you are full member of ShareSoc, as these reports are exclusive to our full members. Further information about access to our AGM reports can be found here.